immatics appoints Dr Rainer Kramer as Chief Business Officer
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing therapeutic vaccines that are activ…
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing therapeutic vaccines that are activ…
Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, announces the appointment o…